U.S. markets closed
  • S&P 500

    4,701.21
    +14.46 (+0.31%)
     
  • Dow 30

    35,754.75
    +35.32 (+0.10%)
     
  • Nasdaq

    15,786.99
    +100.07 (+0.64%)
     
  • Russell 2000

    2,271.71
    +17.92 (+0.80%)
     
  • Crude Oil

    72.54
    +0.18 (+0.25%)
     
  • Gold

    1,784.50
    -1.00 (-0.06%)
     
  • Silver

    22.45
    +0.02 (+0.08%)
     
  • EUR/USD

    1.1347
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5090
    +0.0290 (+1.96%)
     
  • GBP/USD

    1.3207
    +0.0001 (+0.01%)
     
  • USD/JPY

    113.7370
    0.0000 (0.00%)
     
  • BTC-USD

    50,752.64
    +294.72 (+0.58%)
     
  • CMC Crypto 200

    1,320.56
    +15.44 (+1.18%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • Nikkei 225

    28,862.26
    +1.64 (+0.01%)
     

Gilead, Merck pause trial of once-a-week HIV drug combo

·2 min read
Gilead, Merck pause trial of once-a-week HIV drug combo
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

HIV patients already enrolled in the trial will continue to receive the companies' combination therapy.